Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
Science Advances
|
March 11, 2021
α-Synuclein-induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms
Wei-Hua Chiu, Lora Kovacheva, Ruth E Musgrove, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 6, 2011
The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease
James B Koprich, Susan H Fox, Tom H Johnston, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 22, 2018
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
Tom H Johnston, Michal Geva, Lilach Steiner, et al.
Neuropharmacology
|
June 18, 2013
TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque
Tom H Johnston, Philippe Huot, Susan H Fox, et al.
Neurobiology of Disease
|
October 26, 2010
Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism
Ruth Warre, Sherri Thiele, Sheena Talwar, et al.
Plos One
|
March 26, 2013
Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase α3 missense mutant mice
Greer S Kirshenbaum, Neil Dawson, Jonathan G L Mullins, et al.
Acta Neuropathologica Communications
|
February 16, 2020
Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein
Chris McKinnon, Mitchell L De Snoo, Elise Gondard, et al.
Acta Neuropathologica Communications
|
October 8, 2016
Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury
Chi Wang Ip, Ioannis U Isaias, Burak B Kusche-Tekin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 10, 2013
Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit
Karen L Eskow Jaunarajs, David G Standaert, Tacey X Viegas, et al.
Brain : a Journal of Neurology
|
February 18, 2025
Low β predicts motor output and cell degeneration in the A53T Parkinson's disease rat model
Katarina Hofman, Jia Zhi Chen, Tanmoy Sil, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
Science Advances
|
March 11, 2021
α-Synuclein-induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms
Wei-Hua Chiu, Lora Kovacheva, Ruth E Musgrove, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 6, 2011
The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease
James B Koprich, Susan H Fox, Tom H Johnston, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 22, 2018
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques
Tom H Johnston, Michal Geva, Lilach Steiner, et al.
Neuropharmacology
|
June 18, 2013
TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque
Tom H Johnston, Philippe Huot, Susan H Fox, et al.
Neurobiology of Disease
|
October 26, 2010
Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism
Ruth Warre, Sherri Thiele, Sheena Talwar, et al.
Plos One
|
March 26, 2013
Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase α3 missense mutant mice
Greer S Kirshenbaum, Neil Dawson, Jonathan G L Mullins, et al.
Acta Neuropathologica Communications
|
February 16, 2020
Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein
Chris McKinnon, Mitchell L De Snoo, Elise Gondard, et al.
Acta Neuropathologica Communications
|
October 8, 2016
Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury
Chi Wang Ip, Ioannis U Isaias, Burak B Kusche-Tekin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 10, 2013
Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit
Karen L Eskow Jaunarajs, David G Standaert, Tacey X Viegas, et al.
Brain : a Journal of Neurology
|
February 18, 2025
Low β predicts motor output and cell degeneration in the A53T Parkinson's disease rat model
Katarina Hofman, Jia Zhi Chen, Tanmoy Sil, et al.
Page
of 13